About Dr Agarwals Eye Hospital Ltd
Dr Agarwals Eye Hospital is primarily engaged in running, owning and managing eye care hospitals, opticals, pharmacies, etc. and related services.
Founded
1994
CEO
Amar Agarwal.
Employees
1,255
HQ
Chennai, India
Finished Products
1Income from Surgeries
₹253.90Cr2Income from Services
₹241.67Cr3Contact Lens & Accessories-Trd
₹62.39Cr4Pharmaceutical Products-Traded
₹56.55Cr5Optical - Traded
₹48.16Cr6Income from Treatments and Inv
₹34.75Cr7Income from Consultation
₹13.02Cr1–7 of 8
Raw Materials
1Opticals-Traded
₹42.41Cr2Pharmaceutical Products
₹18.49Cr3Pharmacy-Purchases
₹16.22Cr4Contact Lenses-Purchased
₹1.03Cr5Provisions Food Items - Traded
₹0.91CrAbout Dr Agarwals Eye Hospital Ltd
Dr Agarwals Eye Hospital is primarily engaged in running, owning and managing eye care hospitals, opticals, pharmacies, etc. and related services.
Founded:1994
CEO:Amar Agarwal.
Employees:1,255
HQ:Chennai, India
Finished Products
1Income from Surgeries
₹253.90Cr2Income from Services
₹241.67Cr3Contact Lens & Accessories-Trd
₹62.39Cr4Pharmaceutical Products-Traded
₹56.55Cr5Optical - Traded
₹48.16Cr6Income from Treatments and Inv
₹34.75Cr7Income from Consultation
₹13.02Cr1–7 of 8
Raw Materials
1Opticals-Traded
₹42.41Cr2Pharmaceutical Products
₹18.49Cr3Pharmacy-Purchases
₹16.22Cr4Contact Lenses-Purchased
₹1.03Cr5Provisions Food Items - Traded
₹0.91CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹6,060
52W Low
₹4,600
Volume2.32K
Avg VolumeN/A
Beta0.41
Dividend Yield0.07%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
34.33x
Valuation
P/B Ratio
7.56x
Valuation
EPS
₹157.71
Valuation
Dividend Yield
0.07%
Valuation
ROE
20.24%
Profitability
ROCE
15.63%
Profitability
Revenue by Segment
Contribution & growth by business line
Eye care related sales and serviceRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
100.0%
International
0.0%
Within India100.0%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.94x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
14.0%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.